Table S2. Risk of fatal events by Omega-3 Index (n = 2500).
Hazard ratios (95% CIs) |
||||
---|---|---|---|---|
CVD mortality | Cancer mortality | Other mortality | Any mortality | |
Omega-3 Index–unadjusted | ||||
<4.2% (n = 508) | 1.0 | 1.0 | 1.0 | 1.0 |
4.2%–4.9% (n = 500) | 0.97 (0.41, 2.30) | 0.94 (0.58, 1.55) | 0.59 (0.34, 1.02) | 0.81 (0.59, 1.12) |
4.9%–5.7% (n = 501) | 0.96 (0.43, 2.16) | 0.88 (0.50, 1.57) | 0.63 (0.36, 1.09) | 0.78 (0.56, 1.10) |
5.7%–6.8% (n = 502) | 1.10 (0.46, 2.62) | 0.72 (0.42, 1.23) | 0.67 (0.40, 1.11) | 0.73 (0.53, 1.02) |
>6.8% (n = 489) | 0.88 (0.39, 2.01) | 1.19 (0.72, 1.97) | 0.53 (0.31, 0.91) * | 0.81 (0.58, 1.12) |
P-value for linear trend | .86 | .85 | .07 | .16 |
Omega-3 Index–adjusted§ | ||||
<4.2% (n = 508) | 1.0 | 1.0 | 1.0 | 1.0 |
4.2%–4.9% (n = 500) | 0.57 (0.23, 1.40) | 0.66 (0.38, 1.14) | 0.54 (0.31, 0.94) * | 0.74 (0.53, 1.04) |
4.9%–5.7% (n = 501) | 0.54 (0.20, 1.47) | 0.73 (0.42, 1.28) | 0.38 (0.20, 0.73) † | 0.67 (0.46, 0.96) * |
5.7%–6.8% (n = 502) | 0.56 (0.22, 1.43) | 0.60 (0.35, 1.03) | 0.44 (0.25, 0.79) † | 0.59 (0.41, 0.86) † |
>6.8% (n = 489) | 0.39 (0.15, 1.02) | 0.96 (0.56, 1.64) | 0.44 (0.24, 0.79) † | 0.66 (0.45, 0.96) * |
P-value for linear trend | .10 | .88 | .009 † | .02 * |
CVD, cardiovascular disease; CI, confidence interval.
P < .05
P < .01
P < .001.
All significant hazard ratios/P-values are shown in bold italics.
Adjusted for all variables in Table 1 except baseline CVD.